CD24 and allergic asthma: In this study, it was demonstrated that EXO-CD24 increased survival in an animal model of pulmonary sepsis and that it had positive effects in a model of ovalbumin type I-induced allergic asthma, as well as a model of bleomycin-induced pulmonary fibrosis.